News
COR
227.62
+0.22%
0.51
Evercore ISI Keeps Their Buy Rating on Cencora (COR)
TipRanks · 2d ago
Cencora Earnings Preview: What to Expect
Cencora, Inc. Is a pharmaceutical sourcing and distribution company. The company is expected to announce its Q3 earnings before the market opens on Wednesday, July 31. Analysts expect Cencora to report a profit of $3.18 per share. COR stock has rallied 8.9% on a YTD basis. The consensus opinion on COR stock is bullish.
Barchart · 4d ago
Weekly Report: what happened at COR last week (0715-0719)?
Weekly Report · 4d ago
Barclays Sticks to Its Buy Rating for Cencora (COR)
TipRanks · 4d ago
McKesson, Cardinal, Cencora interested in buying private cancer clinics - report
Seeking Alpha · 07/17 21:51
TimesSquare Capital U.S. FOCUS Growth Equity Q2 2024 Commentary
TimesSquare Capital U.S. Small Cap Growth portfolio outperformed the Russell 2000 Growth Index in the second quarter. The second quarter was good for the equity markets. Momentum continued to be the dominant global market factor. Consumer spending remains tight, and the narrative for technology continues to be positive.
Seeking Alpha · 07/16 09:30
Weekly Report: what happened at COR last week (0708-0712)?
Weekly Report · 07/15 09:12
The Highest Quality Dividend Growth Stocks In 2024
Seeking Alpha · 07/09 13:00
Weekly Report: what happened at COR last week (0701-0705)?
Weekly Report · 07/08 09:13
Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
Cencora, Inc. Plans to release its results for the Third Quarter of Fiscal 2024 on July 31, 2024. The Company will host a conference call to discuss the results at 8:30 a.m. ET. The live call will be webcast via the Company’s website at investor.cencora.com. Replays of the call will also be made available via telephone and webcast.
Barchart · 07/05 15:15
McKesson Corporation: An Interesting Health Giant With A Hidden Gem
McKesson Corporation is a large player in the medical space with a market capitalization of $75.86 billion. The company has shown attractive top-line growth, but bottom-line results have been disappointing. The most interesting segment of the business is the Prescription Technology Solutions segment, showing impressive growth and profitability.
Seeking Alpha · 07/04 10:08
June 2024 New Analysts Cover Uber, TG Therapeutics, CarMax, And More
21 new analysts joined Seeking Alpha in June and are highlighted today. They cover a range of sectors including biotech, technology, consumer staples, and real estate. New analysts cover Uber, TG Therapeutics, CarMax, Grab Holdings, and more. Each is highlighted with their first-ever investment thesis on Seeking Alpha.
Seeking Alpha · 07/02 17:00
Weekly Report: what happened at COR last week (0624-0628)?
Weekly Report · 07/01 09:13
Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning
Seeking Alpha · 06/30 11:31
Earnings Scorecard: Nike loses air after shocker results send shares sliding
In the last week of June, eight S&P companies disclosed their earnings. The biggest action of the week came from Nike after its FY sales and FQ1 guidance landed short of expectations. Of the eight companies that reported, two missed on revenue and one beat the average analyst consensus for both.
Seeking Alpha · 06/29 18:45
Buy Rating on Cencora’s Stock Amidst Walgreens Store Closures: Assessing Minimal EBIT Impact and Market Overreaction
TipRanks · 06/28 09:26
CVS, Cencora drop as Walgreens announces store closures
Walgreens Boots Alliance announced a major round of store closures as part of a company-wide strategic review. The drug store chain's Q3 results for fiscal 2024 fell short of Wall Street's forecasts. CVS Health and Cencora's stock drops as Walgreens announces store closures.
Seeking Alpha · 06/27 15:54
Stocks Finish Slightly Higher on Fed Optimism
Stocks recovered from early losses on Thursday to close slightly higher. Micron Technology, Walgreens Boots Alliance and International Paper all closed lower. Weaker-than-expected US economic reports knocked bond yields lower. Atlanta Fed President Bostic said he expects one interest rate cut this year in the fourth quarter.
Barchart · 06/27 15:49
Cencora’s Resilience Amidst WBA Headwinds Affirms Buy Rating
TipRanks · 06/27 14:35
Stocks Recover on Fed-Friendly US Economic Reports
US stock indexes today are mixed after weaker-than-expected economic reports knocked bond yields lower. Atlanta Fed President Bostic says he expects one interest rate cut this year in the fourth quarter. Micron Technology, Walgreens Boots Alliance and International Paper are down after disappointing quarterly results. The markets are awaiting the release of the US May core PCE deflator to see if inflation is slowing.
Barchart · 06/27 10:31
More
Webull provides a variety of real-time COR stock news. You can receive the latest news about Cencora Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COR
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.